End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
775,000 KRW | +0.65% | -3.37% | +1.97% |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
Apr. 25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
ETFs positioned on Samsung Biologics Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.63% | 2 M€ | -14.14% | ||
0.92% | 11 M€ | -.--% | - | |
0.43% | 15 M€ | +13.33% | ||
0.15% | 441 M€ | +5.00% | - | |
0.15% | 2,808 M€ | +6.31% | - | |
0.15% | 149 M€ | +3.21% | - | |
0.13% | 4 M€ | -4.41% | - | |
0.07% | 11 M€ | +2.69% | ||
0.05% | 117 M€ | +1.54% | - | |
0.04% | 7 M€ | +2.68% | - | |
0.02% | 34 M€ | +6.75% | - | |
0.01% | 302 M€ | +4.26% | - | |
0.01% | 39 M€ | +4.26% | - | |
0.01% | 389 M€ | +6.81% | - | |
0.01% | 108 M€ | +1.85% | - | |
0.01% | 17 M€ | +1.67% | - | |
0.01% | 147 M€ | +4.88% | - | |
0.01% | 52 M€ | -0.30% | - | |
0.01% | 8 M€ | -0.23% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 34 M€ | +2.43% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 40.1B | |
-3.45% | 87.17B | |
+58.24% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+6.89% | 8.81B | |
-10.53% | 8.24B | |
+0.95% | 7.62B |
- Stock Market
- Equities
- A207940 Stock
- Funds and ETFs Samsung Biologics Co.,Ltd.